Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF

Evaluation of microRNA-192 in patients with diabetic nephropathy

The Egyptian Journal of Internal Medicine volume 31, pages 122–128 (2019)Cite this article

Abstract

Background

Diabetic nephropathy (DN) is the leading cause of kidney failure. The role of microRNAs (miRs) which are endogenous RNA oligonucleotides that regulate gene expression in DN is not yet clearly established. This study was designed to evaluate the blood level of miR-192 and its relation to disease severity in patients with type 2 diabetes mellitus with and without DN evidenced by the presence of albuminuria.

Materials and methods

The study included 60 patients (37 women and 23 men) with type 2 diabetes mellitus and 20 healthy control participants. All were subjected to thorough history taking, clinical evaluation and measurement of glycosylated hemoglobin, creatinine and urinary albumin/creatinine ratio. miR-192 was quantified in blood using reverse transcription TaqMan microRNA assay.

Results

The study showed that the miR-192 levels were significantly higher in patients with lower estimated glomerular filtration rate and higher albumin/creatinine ratio.

Conclusion

These findings may help to find a new marker for early detection of DN and this could be used in the future as a novel therapeutic target for the treatment of DN.

References

  1. Kate S, Alexa W, Donald JF, Timothy B. MicroRNAs in diabetic nephropathy: from biomarkers to therapy. Curr Diab Rep 2016; 16:35.

    Article  Google Scholar 

  2. Kantharidis P, Wang B, Rosemarie MC, Lan HY. Diabetes complications: the MicroRNA perspective. Diabetes 2011; 60:1832–1837.

    Article  CAS  Google Scholar 

  3. Wu H, Kong L, Zhou S, Cui W, Xu F, Luo M, et al. The role of MicroRNAs in diabetic nephropathy. J Diab Res 2014; 920134:12.

    Google Scholar 

  4. Karalliedde J, Viberti G. Proteinuria in diabetes: bystander or pathwayto cardiorenal disease? J AM Soc Nephrol 2010; 21:2020–2027.

    Article  CAS  Google Scholar 

  5. American Diabetes Association. Microvascular complications and foot care diabetes care. Diabetes Care 2017; 40(Suppl 1):S88–S98.

    Google Scholar 

  6. Alev Y, Asuman G, Zeynep YY, Cemile P, Basak S, Aysegul S, et al. Higher urine heat shock protein 70/creatinine ratio in type 1 diabetes mellitus. Ren Fail 2016; 38:404–410.

    Article  Google Scholar 

  7. Kato M, Park JT, Natarajan R. MicroRNAs and the glomerulus. Exp Cell Res 2012; 318:993–1000.

    Article  CAS  Google Scholar 

  8. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 2004; 25:971–1010.

    Article  CAS  Google Scholar 

  9. Hung-Yu C, Chang-Yi C, Yen-Hui C, Yi-Chun L, Wan-Chun L. Differential microRNA profiles predict diabetic nephropathy progression in Taiwan. Int J Med Sci 2016; 13:457–465.

    Article  Google Scholar 

  10. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382:260–272.

    Article  Google Scholar 

  11. Alvarez ML, DiStefano JK. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression. Diabetes Res Clin Pract 2013; 99:1–11.

    Article  CAS  Google Scholar 

  12. Trionfini P, Benigni A, Remuzzi G. MicroRNAs in kidney physiology and disease. Nat Rev Nephrol 2015; 11:23–33.

    Article  CAS  Google Scholar 

  13. Bartel DP. Micro RNAs: target recognition and regulatory functionsX. Cell 2009; 136:215–233.

    Article  CAS  Google Scholar 

  14. Hamdia E, Abdelwahab ML, Fatma AA, Gihan AM, Hend MT, Amany MA, et al. Expression of micro RNA192 in type 2 diabetes mellitus relation to glycemic control, metabolic abnormalities, renal and ocular complications. Am J Biochem 2013; 3:97–106.

    Google Scholar 

  15. Cai X, Xia Z, Zhang C, Luo Y, Gao Y, Fan Z, et al. Serum microRNAs levels in primary focal segmental glomerulosclerosis. Pediatr Nephrol 2013; 28:1797–1801.

    Article  Google Scholar 

  16. Kato M, Arce L, Wang M, Putta S, Lanting L, Natarajan R. A microRNA circuit mediates transforming growth factor-beta1 autoregulation in renal glomerular mesangial cells. Kidney Int 2011; 80:358–368.

    Article  CAS  Google Scholar 

  17. Chung AC, Huang XR, Meng X, Lan HY. microRNA-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 2010; 21:1317–1325.

    Article  CAS  Google Scholar 

  18. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 2007; 104:3432–3437.

    Article  CAS  Google Scholar 

  19. Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I, et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 2009; 11:881–889.

    Article  CAS  Google Scholar 

  20. Qi W, Chen X, Gilbert RE, Zhang Y, Waltham M, Schache M, et al. High glucose-induced thioredoxin interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1. Am J Pathol 2007; 171:744–754.

    Article  CAS  Google Scholar 

  21. Wang Q, Wang Y, Minto AW, Wang J, Shi Q, Li X, et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. Faseb J 2008; 22:4126–4135.

    Article  CAS  Google Scholar 

  22. Chung AC, Dong Y, Yang W, Zhong X, Li R, Lan HY. Smad7 suppresses renal fibrosis via altering expression of TGF-beta/Smad3-regulated microRNAs. Mol Ther 2013; 21:388–398.

    Article  CAS  Google Scholar 

  23. Putta S, Lanting L, Sun G, Lawson G, Kato M, Natarajan R. Inhibiting MicroRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol 2012; 23:458–469.

    Article  CAS  Google Scholar 

  24. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D. Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 2010; 21:438–447.

    Article  CAS  Google Scholar 

  25. Shu Y, Pi F, Sharma A, Rajabi M, Haque F, Shu D, et al. Stable RNA nanoparticles as potential new generation drugs for cancer therapy. Adv Drug Deliv Rev 2014; 66:74–89.

    Article  CAS  Google Scholar 

  26. Sun L, Zhang D, Liu F, Xiang X, Ling G, Xiao L, et al. Low dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating microRNA-192. J Pathol 2011; 225:364–377.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, 11731, Egypt

    Gamal Saadi, Amr El Meligi, Alkhateeb Alkemary & Ghada Ahmed MSc

  2. Department of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt

    Mervat El-Ansary

Authors
  1. Gamal Saadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amr El Meligi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mervat El-Ansary
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alkhateeb Alkemary
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ghada Ahmed MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ghada Ahmed MSc.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saadi, G., El Meligi, A., El-Ansary, M. et al. Evaluation of microRNA-192 in patients with diabetic nephropathy. Egypt J Intern Med 31, 122–128 (2019). https://doi.org/10.4103/ejim.ejim_89_18

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_89_18

Keywords